Omic approaches to decipher the molecular mechanisms of fibrosis, and design new anti-fibrotic strategies

Semin Cell Dev Biol. 2020 May:101:161-169. doi: 10.1016/j.semcdb.2019.12.009. Epub 2019 Dec 27.

Abstract

We review here omics approaches including transcriptomics, proteomics, glycomics, metabolomics and interactomics, databases and computational tools for omic and multi-omic investigations of fibrosis to understand the molecular mechanisms underlying fibrogenesis and fibrosis, to identify biomarkers of diagnosis, prognosis or disease progression, and new therapeutic targets and to design new anti-fibrotic drugs. We also provide perspectives for future studies including lipid and glycosaminoglycan profiling, and the design of virtual patient models as a basis for personalised medicine and virtualisation of drug development.

Keywords: Databases; Extracellular matrix; Fibrosis; Networks; Omics; Systems biology.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antifibrinolytic Agents / therapeutic use*
  • Computational Biology*
  • Fibrosis* / diagnosis
  • Fibrosis* / drug therapy
  • Fibrosis* / metabolism
  • Humans
  • Metabolomics
  • Proteomics

Substances

  • Antifibrinolytic Agents